Researchers say study findings may lead to a more promising future for cell therapy targeting stroke and other neurological disorders.

Gain Corporation is rated a hold after exceeding my initial price target and experiencing a sharp post-earnings selloff.

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical ...

The 2025 series of the Decision Advantage Sprint for Human-Machine Teaming marked a significant step forward in the ...

Every online bank transfer, private message and Bitcoin transaction rests on the assumption that some math problems are ...

Background Annually, 4% of the global population undergoes non-cardiac surgery, with 30% of those patients having at least ...

Discover what a factor rate is and how to calculate it.

Main outcome measures Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed ...

Trader Joe's has quietly become one of the most reliable places in the country to find wine that tastes far more expensive ...

On January 1, 2026, California launched something unprecedented: the Delete Request and Opt-Out Platform (DROP), enabling ...

Floquet control uses time-periodic drives to engineer quantum systems, creating dynamic changes in material properties ...

Factor V Leiden (FVL) is a change in your genes that affects one of the clotting factors in your blood and keeps your body's blood-clotting process from working right. It can cause a disorder called ...